Login to Your Account

Financings Roundup

ImmunoGen Seeks $35M Via Uncommon Public Offering

By Jennifer Boggs

Friday, June 19, 2009
Adding itself to the short list of firms daring to brave the public markets this year, ImmunoGen Inc. aims to bolster its balance sheet with a public offering of 5 million shares priced at $7 each for $35 million in gross proceeds. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription